Tom Peters: McKinsey’s work on opioid sales represents a new low

Lincoln Wylie

The writer is an creator on management and his following book is ‘Excellence Now: Extraordinary Humanism’

This month McKinsey agreed to pay back approximately $600m to settle promises that its information had exacerbated the lethal US opioid crisis.

The consultancy suggested Purdue Pharma on having to pay “rebates” to pharmacies based on the quantity of people today who died or turned addicted after using the company’s painkiller OxyContin. A person 2017 presentation bloodlessly calculated that if Purdue paid out $fourteen,810 per “event”, and two,484 buyers of the CVS pharmacy chain overdosed or turned addicted in 2019, Purdue would pay back CVS $36.8m that yr.

As a McKinsey alumnus, my reaction was merely: “Dear God!” My a long time of pride in the company evaporated as I read through of the settlement. In truth, I asked a colleague, in earnest: “Should I eliminate McKinsey from my CV?”

Stepping back again, I

Read More